Merkel Cell Carcinoma Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.A Study of T-VEC (Talimogene Laherparepvec) With or Without Radiotherapy for Melanoma, Merkel Cell Carcinoma, or Other Solid Tumors
Conditions: Melanoma; Merkel Cell Carcinoma; Other Solid TumorsInterventions: Drug: TALIMOGENE LAHERPAREPVEC (TVEC); Radiation: Hypofractionated RadiotherapySponsors: Memorial Sloan Kettering Cancer Center; AmgenRecruiting - verified June 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 28, 2016 Category: Research Source Type: clinical trials
